The International Neuromodulation Society defines therapeutic neuromodulation as “the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body.” In appropriate patients, this growing class of therapies, in common use since the 1980s, can help restore function or relieve symptoms that have a neurological basis.
controls pain of nerve origin
avoids side effects of narcotics
HBOT can improve dysexecutive functions, psychiatric symptoms (depression, anxiety and somatisation), pain interference symptoms and fatigue of patients suffering from post-COVID condition.
Restoration of glutathione levels in COVID-19 patients would be a promising approach for the management of the novel coronavirus SARS-CoV-2.
Spinal cord stimulation has seen unprecedented growth in new technology in the 50 years since the first subdural implant. As we continue to grow our understanding of spinal cord stimulation and relevant mechanisms of action, novel questions arise as to electrical dosing optimization.
A new approach to spinal cord stimulation may drastically reduce chronic back pain, a small pilot study suggests.